Bayer, J&J win first trial over Xarelto bleeding risks - Reuters

Reuters

Bayer, J&J win first trial over Xarelto bleeding risks Reuters Members of the supervisory board of German pharmaceutical and chemical maker Bayer AG are silhouetted against the company's logo at the annual general shareholders meeting in Bonn, Germany, April 28, 2017. REUTERS/Wolfgang Rattay. 1/2. left. right. and more »

from Health - Google News http://ift.tt/2pZUkM6